232 related articles for article (PubMed ID: 29432785)
1. Expression of MDM2 and p16 in angiomyolipoma.
Lin X; Laskin WB; Lu X; Zhang Y
Hum Pathol; 2018 May; 75():34-40. PubMed ID: 29432785
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic utility of p16, CDK4, and MDM2 as an immunohistochemical panel in distinguishing well-differentiated and dedifferentiated liposarcomas from other adipocytic tumors.
Thway K; Flora R; Shah C; Olmos D; Fisher C
Am J Surg Pathol; 2012 Mar; 36(3):462-9. PubMed ID: 22301498
[TBL] [Abstract][Full Text] [Related]
3. A subset of fat-predominant angiomyolipomas label for MDM2: a potential diagnostic pitfall.
Asch-Kendrick RJ; Shetty S; Goldblum JR; Sharma R; Epstein JI; Argani P; Cimino-Mathews A
Hum Pathol; 2016 Nov; 57():7-12. PubMed ID: 27369456
[TBL] [Abstract][Full Text] [Related]
4. MDM2 RNA In Situ Hybridization for the Diagnosis of Atypical Lipomatous Tumor: A Study Evaluating DNA, RNA, and Protein Expression.
Kulkarni AS; Wojcik JB; Chougule A; Arora K; Chittampalli Y; Kurzawa P; Mullen JT; Chebib I; Nielsen GP; Rivera MN; Ting DT; Deshpande V
Am J Surg Pathol; 2019 Apr; 43(4):446-454. PubMed ID: 30520819
[TBL] [Abstract][Full Text] [Related]
5. p16 Expression in Fat Necrosis: A Potential Diagnostic Pitfall in the Evaluation of Differentiated Adipocytic Neoplasms.
Ng W; Messiou C; Smith M; Thway K
Int J Surg Pathol; 2015 Oct; 23(7):544-8. PubMed ID: 26173427
[TBL] [Abstract][Full Text] [Related]
6. Differential diagnosis of atypical lipomatous tumor/well-differentiated liposarcoma and dedifferentiated liposarcoma: utility of p16 in combination with MDM2 and CDK4 immunohistochemistry.
Kammerer-Jacquet SF; Thierry S; Cabillic F; Lannes M; Burtin F; Henno S; Dugay F; Bouzillé G; Rioux-Leclercq N; Belaud-Rotureau MA; Stock N
Hum Pathol; 2017 Jan; 59():34-40. PubMed ID: 27597521
[TBL] [Abstract][Full Text] [Related]
7. The value of MDM2 and CDK4 amplification levels using real-time polymerase chain reaction for the differential diagnosis of liposarcomas and their histologic mimickers.
Shimada S; Ishizawa T; Ishizawa K; Matsumura T; Hasegawa T; Hirose T
Hum Pathol; 2006 Sep; 37(9):1123-9. PubMed ID: 16938516
[TBL] [Abstract][Full Text] [Related]
8. Utility of fluorescence in situ hybridization to detect MDM2 amplification in liposarcomas and their morphological mimics.
Kimura H; Dobashi Y; Nojima T; Nakamura H; Yamamoto N; Tsuchiya H; Ikeda H; Sawada-Kitamura S; Oyama T; Ooi A
Int J Clin Exp Pathol; 2013; 6(7):1306-16. PubMed ID: 23826411
[TBL] [Abstract][Full Text] [Related]
9. p16 immunohistochemistry as an alternative marker to distinguish atypical lipomatous tumor from deep-seated lipoma.
He M; Aisner S; Benevenia J; Patterson F; Aviv H; Hameed M
Appl Immunohistochem Mol Morphol; 2009 Jan; 17(1):51-6. PubMed ID: 18779733
[TBL] [Abstract][Full Text] [Related]
10. Rare MDM2 amplification in a fat-predominant angiomyolipoma.
Rodriguez Pena MDC; Gordetsky J; Greipp PT; Wei S; Martignoni G; Netto GJ; Harada S; Prieto Granada CN
Virchows Arch; 2020 Nov; 477(5):661-666. PubMed ID: 32409886
[TBL] [Abstract][Full Text] [Related]
11. Immunoreactivity of p53, mdm2, and p21WAF1 in dedifferentiated liposarcoma: special emphasis on the distinct immunophenotype of the well-differentiated component.
Adachi T; Oda Y; Sakamoto A; Saito T; Tamiya S; Masuda K; Tsuneyoshi M
Int J Surg Pathol; 2001 Apr; 9(2):99-109. PubMed ID: 11484509
[TBL] [Abstract][Full Text] [Related]
12. Comparison between retroperitoneal leiomyosarcoma and dedifferentiated liposarcoma.
Ishii T; Kohashi K; Ootsuka H; Iura K; Maekawa A; Yamada Y; Bekki H; Yoshimoto M; Yamamoto H; Iwamoto Y; Oda Y
Pathol Res Pract; 2017 Jun; 213(6):634-638. PubMed ID: 28552535
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic importance of clinicopathologic features and p16, CD34, MDM2 expression in differential diagnosis of adipocytic tumors.
Altun E; Yüksel S; Kaygusuz G; Yıldız HY
Acta Orthop Traumatol Turc; 2020 Jan; 54(1):59-65. PubMed ID: 32175898
[TBL] [Abstract][Full Text] [Related]
14. Overlapping features between dedifferentiated liposarcoma and undifferentiated high-grade pleomorphic sarcoma.
Chung L; Lau SK; Jiang Z; Loera S; Bedel V; Ji J; Weiss LM; Chu PG
Am J Surg Pathol; 2009 Nov; 33(11):1594-600. PubMed ID: 19574885
[TBL] [Abstract][Full Text] [Related]
15. Atypical Lipomatous Tumor/Well-Differentiated Liposarcoma With Features Mimicking Spindle Cell Lipoma.
Jebastin JAS; Perry KD; Chitale DA; Mott MP; Sanchez J; Fritchie KJ; Palanisamy N; Williamson SR
Int J Surg Pathol; 2020 May; 28(3):336-340. PubMed ID: 31672072
[TBL] [Abstract][Full Text] [Related]
16. Well-Differentiated Liposarcoma With Hibernoma-Like Morphology.
Hallin M; Schneider N; Thway K
Int J Surg Pathol; 2016 Oct; 24(7):620-2. PubMed ID: 27272683
[TBL] [Abstract][Full Text] [Related]
17. Expression of FRS2 in atypical lipomatous tumor/well-differentiated liposarcoma and dedifferentiated liposarcoma: an immunohistochemical analysis of 182 cases with genetic data.
Jing W; Lan T; Qiu Y; Peng R; Lu Y; Chen H; Chen M; He X; Chen C; Zhang H
Diagn Pathol; 2021 Oct; 16(1):96. PubMed ID: 34696768
[TBL] [Abstract][Full Text] [Related]
18. Nuclear expression of MDM2 in hibernoma: a potential diagnostic pitfall.
Tsuda Y; Matsuyama A; Makihara K; Higaki K; Motoi T; Okuma T; Hisaoka M
Virchows Arch; 2021 Mar; 478(3):527-534. PubMed ID: 32815035
[TBL] [Abstract][Full Text] [Related]
19. Amplification of FRS2 in atypical lipomatous tumour/well-differentiated liposarcoma and de-differentiated liposarcoma: a clinicopathological and genetic study of 146 cases.
Jing W; Lan T; Chen H; Zhang Z; Chen M; Peng R; He X; Zhang H
Histopathology; 2018 Jun; 72(7):1145-1155. PubMed ID: 29368794
[TBL] [Abstract][Full Text] [Related]
20. Lipomas of the Oral Cavity: Utility of MDM2 and CDK4 in Avoiding Overdiagnosis as Atypical Lipomatous Tumor.
Stojanov IJ; Mariño-Enriquez A; Bahri N; Jo VY; Woo SB
Head Neck Pathol; 2019 Jun; 13(2):169-176. PubMed ID: 29748845
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
